Atomic force mechanobiology of pluripotent stem cell-derived cardiomyocytes

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Liu, Jianwei ^a   Sun, Ning ^b   Bruce, Marc A ^a   Wu, Joseph C ^b   Butte, Manish J ^a  

^a STANFORD UNIVERSITY   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METOPROLOL; NORADRENALIN; BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT;

ARTICLE; ATOMIC FORCE MICROSCOPY; CELLULAR ELASTICITY; CELLULAR PARAMETERS; CONCENTRATION RESPONSE; CONGESTIVE CARDIOMYOPATHY; CONTRACTION DURATION; CONTRACTION FORCE; CONTRACTION RATE; CONTROLLED STUDY; EMBRYO; EMBRYONIC STEM CELL; HEART MUSCLE CELL; HUMAN; HUMAN CELL; INOTROPISM; PLURIPOTENT STEM CELL; BIOMECHANICS; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; ELASTICITY; HEART CONTRACTION; METHODOLOGY; PHYSIOLOGY;

ADRENERGIC BETA-1 RECEPTOR ANTAGONISTS; BIOMECHANICS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELASTICITY; METOPROLOL; MICROSCOPY, ATOMIC FORCE; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; NOREPINEPHRINE; PLURIPOTENT STEM CELLS;

EID: 84862098739     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0037559     Document Type: Article

References (23)

1. Mathers CD, Loncar D, (2006) Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 3: e442.
2. Yamanaka S, (2007) Strategies and new developments in the generation of patient-specific pluripotent stem cells. Cell Stem Cell 1: 39-49.
3. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, et al. (2007) Induced pluripotent stem cell lines derived from human somatic cells. Science 318: 1917-1920.
4. Hockemeyer D, Jaenisch R, (2010) Gene targeting in human pluripotent cells. Cold Spring Harb Symp Quant Biol 75: 201-209.
5. Domke J, Parak W, George M, Gaub H, Radmacher M, (1999) Mapping the mechanical pulse of single cardiomyocytes with the atomic force microscope. European Biophysics Journal 28: 179-186.
6. Pelling AE, Veraitch FS, Chu CPK, Nicholls BM, Hemsley AL, et al. (2007) Mapping correlated membrane pulsations and fluctuations in human cells. Journal of Molecular Recognition 20: 467-475.
7. Shroff S, Saner D, Lal R, (1995) Dynamic micromechanical properties of cultured rat atrial myocytes measured by atomic force microscopy. American Journal of Physiology- Cell Physiology 269: C286.
8. Hutter JL, Bechhoefer J, (1993) CALIBRATION OF ATOMIC-FORCE MICROSCOPE TIPS. Review of Scientific Instruments 64: 1868-1873.
9. Sun N, Yazawa M, Liu J, Navarrete EG, Sanchez-Freire V, et al. (2012) Patient-specific induced pluripotent stem cell as a model for familial dilated cardiomyopathy. Science Translational Medicine In press.
10. Yang L, Soonpaa MH, Adler ED, Roepke TK, Kattman SJ, et al. (2008) Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population. Nature 453: 524-528.
11. Stickle D, Barber R, (1989) Evidence for the role of epinephrine binding frequency in activation of adenylate cyclase. Mol Pharmacol 36: 437-445.
12. Hershberger RE, Cowan J, Morales A, Siegfried JD, (2009) Progress with genetic cardiomyopathies: screening, counseling, and testing in dilated, hypertrophic, and arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circ Heart Fail 2: 253-261.
13. Maron BJ, Towbin JA, Thiene G, Antzelevitch C, Corrado D, et al. (2006) Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 113: 1807-1816.
14. Van Acker H, De Sutter J, Vandekerckhove K, de Ravel TJ, Verhaaren H, et al. (2010) Dilated cardiomyopathy caused by a novel TNNT2 mutation-added value of genetic testing in the correct identification of affected subjects. Int J Cardiol 144: 307-309.
15. Wollert KC, Drexler H, (2005) Clinical applications of stem cells for the heart. Circ Res 96: 151-163.
16. Sehnert AJ, Huq A, Weinstein BM, Walker C, Fishman M, et al. (2002) Cardiac troponin T is essential in sarcomere assembly and cardiac contractility. Nature Genetics 31: 106-110.
17. Matsa E, Rajamohan D, Dick E, Young L, Mellor I, et al. (2011) Drug evaluation in cardiomyocytes derived from human induced pluripotent stem cells carrying a long QT syndrome type 2 mutation. Eur Heart J 32: 952-962.
18. Balligand JL, Kelly RA, Marsden PA, Smith TW, Michel T, (1993) Control of cardiac muscle cell function by an endogenous nitric oxide signaling system. Proc Natl Acad Sci U S A 90: 347-351.
19. Sabri A, Alcott SG, Elouardighi H, Pak E, Derian C, et al. (2003) Neutrophil cathepsin G promotes detachment-induced cardiomyocyte apoptosis via a protease-activated receptor-independent mechanism. J Biol Chem 278: 23944-23954.
20. Oh Y, Wei H, Ma D, Sun X, Liew R, (2012) Clinical applications of patient-specific induced pluripotent stem cells in cardiovascular medicine. Heart 98: 443-449.
21. Park IH, Lerou PH, Zhao R, Huo H, Daley GQ, (2008) Generation of human-induced pluripotent stem cells. Nat Protoc 3: 1180-1186.
22. Sun N, Panetta NJ, Gupta DM, Wilson KD, Lee A, et al. (2009) Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells. Proc Natl Acad Sci U S A 106: 15720-15725.
23. Wickham H, (2009) ggplot2: elegant graphics for data analysis: Springer-Verlag New York Inc.